IBD Quick Notes

IBD Overview

  • IBD is an immune-mediated inflammatory disorder of the gastrointestinal tract, distinguished from classic autoimmune diseases by its unique pathophysiology, which involves complex interactions between genetic, environmental, and immunological factors.

  • Characterized by dysregulated immune responses in the gut, leading to chronic inflammation, ulceration, and tissue damage, substantially impacting the quality of life. The inflammation extends beyond the intestinal lining, affecting deeper tissues and causing structural changes.

  • Triggered by a complex interplay of environmental factors, such as alterations in gut microbiota composition (dysbiosis), specific dietary components (e.g., refined sugars, additives), and lifestyle factors (e.g., smoking, stress), combined with predisposing genetic factors that affect immune regulation, barrier function, and the inflammatory response.

Types and Epidemiology

  • Two main types of IBD: Crohn’s disease (CD) and ulcerative colitis (UC), each with distinct clinical, endoscopic, histological, and immunological features, influencing disease management and prognosis.

  • Increasing incidence worldwide, particularly in developed countries due to industrialization, urbanization, improved sanitation, and changes in lifestyle and diet, suggesting potential environmental and microbial influences. Newly industrialized countries also show rising rates.

  • Onset typically peaks between 15-30 and 50-70 years; more common in females, although specific gender differences may vary with the type of IBD; CD slightly more common in females, while UC has a more balanced gender distribution. Pediatric IBD is also increasingly recognized.

Clinical Features and Symptoms

  • General symptoms: abdominal pain (ranging from mild discomfort to severe cramping), diarrhea (varying from mild to severe, intermittent or persistent), fatigue (often profound and debilitating), weight loss (due to malabsorption and reduced appetite), and anemia (due to chronic inflammation and malabsorption of iron and other nutrients).

  • CD-specific: abdominal cramping (often in the lower right quadrant), significant weight loss (due to small intestinal involvement), fistulas (abnormal connections between organs, such as between the intestine and skin or bladder), perianal disease (e.g., abscesses, fissures, skin tags).

  • UC-specific: bloody diarrhea (often frequent and urgent), tenesmus (feeling of incomplete defecation, leading to frequent toilet visits), rectal bleeding (ranging from mild streaks of blood to significant hemorrhage), and in severe cases, toxic megacolon (an acute, life-threatening dilation of the colon).

Macroscopic and Endoscopic Features

  • Crohn's Disease:

    • Location: Can occur anywhere in the GI tract from the mouth to the anus, commonly affecting the terminal ileum and colon.

    • Distribution: Characterized by skip lesions (affected areas interspersed with normal areas), creating a discontinuous pattern of inflammation.

    • Stricture: Common due to chronic inflammation and fibrosis, leading to narrowing of the intestinal lumen and potential obstruction.

    • Bowel wall: Thickened due to transmural inflammation, edema, and fibrosis, affecting the entire intestinal wall.

    • Endoscopic Findings: Cobblestone appearance (due to crisscrossing ulcers and intervening edema), deep linear ulcers (extending into the submucosa), and aphthous ulcers (small, discrete ulcers).

    • Granulomas: Present in approximately 35% of cases, non-caseating granulomas are a hallmark histological feature.

    • Fistulas*/sinuses: Common, connecting different parts of the intestine or other organs, like the skin, bladder, or vagina.

  • Ulcerative Colitis:

    • Location: Confined to the colon, starting from the rectum and extending proximally in a continuous manner, with varying degrees of proximal extension.

    • Rectal involvement: Almost always involved, and disease activity often correlates with the severity of rectal inflammation.

    • Distribution: Diffuse and continuous inflammation, without skip lesions, affecting the mucosal layer uniformly.

    • Stricture: Rare, except in cases of chronic disease or cancer development, often a sign of dysplasia or malignancy.

    • Bowel wall: Typically thin, but can thicken with chronic inflammation, particularly in long-standing cases.

    • Endoscopic Findings: Friable mucosa (easily bleeds upon contact), pseudopolyps (inflammatory polyps resulting from repeated cycles of ulceration and healing), and superficial ulcerations (limited to the mucosa).

    • Granulomas: Not present, their presence would suggest an alternative diagnosis.

    • Fistulas*/sinuses: Absent, their presence would suggest Crohn’s disease or another condition.

Histological and Immunological Features

  • Crohn’s Disease (CD)

    • Inflammation Depth: Transmural, affecting all layers of the intestinal wall, including the serosa.

    • Histopathology: Non-caseating granulomas (aggregates of immune cells without central necrosis), fissures (deep clefts extending into the submucosa), creeping fat (mesenteric fat wrapping around the bowel), and submucosal fibrosis (collagen deposition).

    • Th Cell Subset: Primarily Th1 and Th17 responses, with increased production of IFN-γ (involved in macrophage activation) and IL-17 (involved in neutrophil recruitment).

  • Ulcerative Colitis (UC)

    • Inflammation Depth: Limited to the mucosal and submucosal layers, sparing the deeper muscle layers.

    • Histopathology: Crypt abscesses (collections of neutrophils in the crypts), pseudopolyps (inflammatory polyps), goblet cell depletion (reduced mucus production), and basal plasmacytosis (increased plasma cells at the base of the crypts).

    • Th Cell Subset: Primarily Th2 and Th9 responses, with increased production of IL-13 (involved in B-cell activation and antibody production) and IL-9 (involved in mast cell activation).